Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2020. Module: SNOMED CT core
Descriptions:
Id | Description | Lang | Type | Status | Case? | Module |
3969302018 | Cytotoxic T-lymphocyte-associated protein 4 inhibitor | en | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3969303011 | Substance with cytotoxic T-lymphocyte-associated protein 4 inhibitor mechanism of action (substance) | en | Fully specified name | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT core |
3969706017 | CTLA-4 (cytotoxic T-lymphocyte-associated protein 4) inhibitor | en | Synonym (core metadata concept) | Active | Entire term case sensitive (core metadata concept) | SNOMED CT core |
4700171000052116 | hämmare av cytotoxiskt T-lymfocytassocierat protein 4 | sv | Synonym (core metadata concept) | Active | Only initial character case insensitive (core metadata concept) | SNOMED CT Sweden NRC maintained module (core metadata concept) |
Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
Cytotoxic T-lymphocyte-associated protein 4 inhibitor | Is a | Substance with immune checkpoint inhibitor mechanism of action (substance) | true | Inferred relationship | Some | ||
Cytotoxic T-lymphocyte-associated protein 4 inhibitor | Has disposition (attribute) | Cytotoxic T-lymphocyte-associated protein 4 inhibitor | true | Inferred relationship | Some |
Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
Ipilimumab | Is a | True | Cytotoxic T-lymphocyte-associated protein 4 inhibitor | Inferred relationship | Some |
This concept is not in any reference sets